Maike Barcik
Overview
Explore the profile of Maike Barcik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Polzin A, Benkhoff M, Thienel M, Barcik M, Mourikis P, Shchurovska K, et al.
J Thromb Haemost
. 2024 Nov;
23(2):668-683.
PMID: 39551435
Background: Immediate activated factor (F)X (FXa) inhibition exerts direct antiplatelet effects in the context of arterial thrombosis but little is known about the impact of long-term therapy on platelet function...
2.
Lang A, Oehler D, Benkhoff M, Reinders Y, Barcik M, Shahrjerdi K, et al.
Biomedicines
. 2024 Oct;
12(10).
PMID: 39457679
Background/objectives: Acute myocardial infarction (AMI), characterized by irreversible heart muscle damage and impaired cardiac function caused by myocardial ischemia, is a leading cause of global mortality. The damage associated with...
3.
Benkhoff M, Barcik M, Mourikis P, Dahlmanns J, Kahmann P, Wollnitzke P, et al.
Circulation
. 2024 Oct;
151(4):333-347.
PMID: 39429140
Background: Aortic valve disease (AVD) is associated with high mortality and morbidity. To date, there is no pharmacological therapy available to prevent AVD progression. Because valve calcification is the hallmark...
4.
Polzin A, Dannenberg L, Benkhoff M, Barcik M, Helten C, Mourikis P, et al.
Nat Commun
. 2023 Apr;
14(1):2404.
PMID: 37100836
Antiplatelet medication is standard of care in acute myocardial infarction (AMI). However, it may have obscured beneficial properties of the activated platelet secretome. We identify platelets as major source of...
5.
Surdin T, Preissing B, Rohr L, Grommke M, Boke H, Barcik M, et al.
iScience
. 2023 Jan;
26(1):105828.
PMID: 36632066
Neuronal plasticity underlying cerebellar learning behavior is strongly associated with type 1 metabotropic glutamate receptor (mGluR1) signaling. Activation of mGluR1 leads to activation of the G pathway, which is involved...
6.
Polzin A, Dannenberg L, Benkhoff M, Barcik M, Keul P, Ayhan A, et al.
ESC Heart Fail
. 2022 Oct;
10(1):334-341.
PMID: 36217778
Aims: Therapeutic options targeting post-ischaemic cardiac remodelling are sparse. The bioactive sphingolipid sphingosine-1-phosphate (S1P) reduces ischaemia/reperfusion injury. However, its impact on post-ischaemic remodelling independently of its infarct size (IS)-reducing effect...
7.
Polzin A, Dannenberg L, Benkhoff M, Barcik M, Keul P, Helten C, et al.
JACC Basic Transl Sci
. 2022 Jun;
7(5):498-499.
PMID: 35663625
No abstract available.
8.
Dannenberg L, Afzal S, Czychy N, MPembele R, Zako S, Helten C, et al.
Int J Cardiol Heart Vasc
. 2021 Mar;
33:100750.
PMID: 33763519
Background: Guidelines recommend the PRECISE-DAPT (PD) score to adapt duration of dual antiplatelet therapy due to bleeding risk. However, there is first evidence that PD predicts mortality and ischemic events...